Sun et al. showed that the patients with NAFLD, normal alanine aminotransferase (ALT) levels, and carriage of PNPLA3 rs738409 G allele were at higher risk of early glomerular and tubular damage (45). The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.